Get Your Apc/fire™ 810 Anti-mouse Ly-6c Satisfaction Guaranteed [WHXqjOMs]

APC/Fire™ 810 Anti-Mouse Ly-6C

The APC/Fire™ 810 Anti-Mouse Ly-6C is a highly specialized monoclonal antibody designed for immunophenotyping and flow cytometry applications. This innovative reagent offers a unique advantage with its APC-Fire™ 810 dye conjugation, providing excellent fluorescence properties for multicolor flow cytometry experiments. With its exceptional sensitivity and specificity, this antibody is ideal for identifying and analyzing Ly-6C-expressing cells, such as mouse monocytes/macrophages, endothelial cells, neutrophils, and certain T cell subsets.

Product Properties and Specifications

The APC/Fire™ 810 Anti-Mouse Ly-6C is produced by BioLegend, Inc., a leading provider of high-quality immunological reagents. This antibody is cloned from rat and conjugated to APC-Fire™ 810, a dye with excellent photostability and high fluorescence intensity. The antibody is further characterized by its mouse specificity and IgG2c, κ isotype. The clone HK1.4 ensures a robust and reliable detection of Ly-6C, making it an essential tool for researchers investigating immune cell subsets and their functions. This product is suitable for flow cytometry applications and has been quality tested for optimal performance.

Practical Uses and Target Audience

The APC/Fire™ 810 Anti-Mouse Ly-6C is an invaluable tool for researchers in various fields, including immunology, oncology, and infectious diseases. Its ability to identify memory CD8+ T cells, along with other Ly-6C-expressing cells, makes it particularly useful for studies on immune responses and disease progression. This antibody is ideal for both basic research and clinical applications, offering numerous benefits such as enhanced sensitivity, reduced cross-reactivity, and increased flexibility in multicolor flow cytometry experiments. By utilizing this product, researchers can gain deeper insights into the complex interactions between different immune cell types and contribute to advancements in our understanding of immune-related diseases.